Ligand Pharmaceuticals赞助的临床试验
总计19790个结果
-
Ligand Pharmaceuticals完全的
-
Ligand Pharmaceuticals完全的
-
Ligand Pharmaceuticals完全的骨质疏松症美国, 澳大利亚, 加拿大, 哥斯达黎加, 德国, 俄罗斯联邦, 法国, 克罗地亚, 南非, 比利时, 日本, 印度, 西班牙, 英国, 意大利, 埃及, 火鸡, 立陶宛, 波兰, 挪威, 爱沙尼亚, 芬兰, 丹麦, 香港, 阿根廷, 巴西, 匈牙利, 爱尔兰, 大韩民国, 墨西哥, 罗马尼亚, 瑞典
-
Ligand PharmaceuticalsCyDex Pharmaceuticals, Inc.撤销
-
Ligand PharmaceuticalsMedpace, Inc.完全的
-
Stanford UniversityAstraZeneca; Ligand Pharmaceuticals完全的
-
Nucorion Pharmaceuticals, Inc.Medpace, Inc.; Ligand Pharmaceuticals完全的
-
CyDex Pharmaceuticals, Inc.Syneos Health; Ligand Pharmaceuticals完全的
-
Ligand PharmaceuticalsMedpace, Inc.; Beckloff Associates, Inc.完全的
-
Dartmouth-Hitchcock Medical CenterGenentech, Inc.; Ligand Pharmaceuticals完全的
-
Dartmouth-Hitchcock Medical CenterGenentech, Inc.; Ligand Pharmaceuticals完全的
-
Lundbeck LLCQuintiles, Inc.; ICON Clinical Research; Ligand Pharmaceuticals完全的
-
Dartmouth-Hitchcock Medical CenterBristol-Myers Squibb; Ligand Pharmaceuticals终止
-
Pharmtechnology LLCLigand Research, LLC完全的
-
Eisai Inc.National Cancer Institute (NCI); Tufts Medical Center; Ligand Pharmaceuticals完全的
-
Pharmaceutical Research Unit, JordanSanofi-aventis Liban SAL撤销
-
University of Lugano完全的Group 1 (Control): Access to a Static Version of the Website Containing Only Static Features (i.e. Library, First Aid, and FAQ) | Group2 (Intervention) Access to an Interactive Version of the Website Containing Both Static and Interactive Features瑞士
-
Novartis PharmaceuticalsChugai Pharmaceutical完全的
-
Novartis PharmaceuticalsChugai Pharmaceutical完全的
-
University of Medicine and Dentistry of New JerseyLigand Pharmaceuticals完全的
-
Novartis PharmaceuticalsPharmaceutical Research Associates撤销
-
Novartis PharmaceuticalsPharmaceutical Research Associates撤销